Orthodontic Supplies Market Size Worth USD 8.3 billion by 2026

 The global Orthodontic Supplies Market size is projected to reach USD 8.3 billion by 2026 from USD 5.4 billion in 2021, at a CAGR of 9.1% during the forecast period. Increasing prevalence of malocclusion, rising emphasis on effective orthodontic treatment and the initiatives undertaken by governments to increase the awareness about orthodontic treatments are fueling the demand for orthodontic supplies during the forecast period.



Browse in-depth TOC on " Orthodontic Supplies Industry"

261 – Tables

29 – Figures

43 – Pages

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=236529189

The orthodontic supplies industry includes major Tier I and II suppliers of orthodontic products are 3M (US), Envista Holdings Corporation (US), Dentsply Sirona (US), Align Technology (US), American Orthodontics (US), Rocky Mountain Orthodontics (US), G&H Orthodontics (US), Dentaurum (Germany), TP Orthodontics (US), Great Lakes Dental Technologies (US), DB Orthodontics (UK), Morelli Orthodontics (Brazil), ClearCorrect (US), and Ultradent Products (US).

These suppliers have their manufacturing facilities spread across regions such as North America and Europe. COVID-19 has impacted their businesses as well. Due to the pandemic, the orthodontic supplies market experienced short-term negative growth, which can be attributed to a sharp reduction in access to hospital and dental clinics and the temporarily shutdown of orthodontic clinics.

Orthodontic practices around the globe are facing challenges amid the pandemic. The adoption of strict protocols outside and inside dental clinics, increasing usage of teleorthodontics in case of urgent appointments, and opting for minimal orthodontic treatment procedures by many orthodontic clinics are likely to have a positive impact on the market. Moreover, post lockdown, as dental practices reopen, it is expected that patient volumes are anticipated to rebound at a higher pace.

Request Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=236529189

Demand for invisible braces among the target population due to their aesthetic benefits drives the growth of removable braces

Removable braces offer advantages over traditional braces, including easy removal of braces, reduced risk of periodontal diseases & tooth decay, and enhanced comfort. Factors such as strong focus on product innovation by players and growing awareness about the benefits associated with removable braces and the growing demand for invisible braces among teens and adults due to their aesthetic benefits is augumenting the growth of removable braces.

Asia Pacific likely to emerge as the fastest growing orthodontic supplies market, globally

Geographically, the emerging Asian countries, such as China, India, Japan and Singapore, are offering high-growth opportunities for market players. The Asia Pacific point of care market is projected to grow at the highest CAGR of 10.8% from 2021 to 2026. Expansion of healthcare infrastructure and increase in disposable personal income, increase patient population with malocclusion and tooth decay are factors likely to suppprt the growth of orthodontic supplies market in the region. Moreover, the growing focus toward aesthetics products among adults and emergence of small manufacturers in the orthodontic supplies market are driving the growth of the APAC orthodontic supplies market.

Prominent players in this market are 3M (US), Envista Holdings Corporation (US), Dentsply Sirona (US), Align Technology (US), Rocky Mountain Orthodontics (US), G&H Orthodontics (US), Dentaurum (Germany), TP Orthodontics (US), Great Lakes Dental Technologies (US), DB Orthodontics (UK), among others

Speak to Analyst:

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=236529189

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

Email: sales@marketsandmarkets.com

Related Reports:

Foot Ankle Devices Market:

https://www.marketsandmarkets.com/Market-Reports/foot-ankle-devices-market-845.html

Orthopedic Braces Support Market:

https://www.marketsandmarkets.com/Market-Reports/orthopedic-braces-support-market-24806829.html

Comments

Post a Comment

Popular posts from this blog

Healthcare Simulation Market Size & Share - Global Future Growth Predictions

Image
 The global healthcare simulation market is projected to reach USD 4.6 billion by 2028 from USD 2.2 billion in 2023, at a high CAGR of 15.7% during the forecast period. The expansion of this market is fueled by the increasing adoption of advanced techniques and methodologies in delivering medical education, along with restricted patient access during medical training. Nevertheless, the market's growth is anticipated to be somewhat hampered by the constrained availability of funds and incomplete replication of medical simulators. Market Size Introduction: The healthcare simulation market size represents the total valuation of products and services within the healthcare simulation industry over a specific period, typically a year. It encompasses various simulation technologies, including manikins, simulators, simulated environments, and software solutions, utilized for medical training, education, and research purposes. Understanding the market size is crucial for stakeholders as ...
Read more

Global Dental Practice Management Software Industry worth $2.3 billion By 2028

Image
 The Global Dental Practice Management Software Market in terms of revenue was estimated to be worth $1.5 billion in 2023 and is poised to reach $2.3 billion in 2028, growing at a CAGR of 8.6% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The rising awareness of oral hygiene and dental treatment, the increasing demand for advanced dental procedures, and the growing market for dental tourism in developing countries are major key drivers for the market. However, data privacy and security issues are the factors which may slow down market growth. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153532396 Dental Practice Management Software Industry Dynamics Driver: Rising demand for advanced cosmetic dental procedures Cosmetic d...
Read more

Humanized Mouse and Rat Model Market worth $349 million by 2028

Image
  In the near future, the humanized mouse and rat model industry is set to undergo transformative advancements, revolutionizing biomedical research and drug development. These cutting-edge models, where mice and rats are genetically modified to possess human-like characteristics and immune systems, will play a pivotal role in bridging the gap between preclinical studies and clinical trials. Through refined genetic engineering techniques, these models will closely mimic human physiology, enabling more accurate and predictive assessments of drug safety, efficacy, and disease mechanisms. Moreover, the industry will witness the integration of advanced technologies, such as CRISPR/Cas9, to expedite the creation of customized humanized models, tailoring them to specific diseases or individual patient profiles. These advancements will spur collaboration between academia, pharmaceutical companies, and biotech firms, fostering a dynamic research ecosystem focused on targeted therapies and p...
Read more